Fengqin Wu is an author at Shangluo Central Hospital specializing in tumor biology, cancer therapeutics, and drug resistance.
Top concepts
HealthMedicineOncologyCell BiologyTumor BiologyCancer BiologyCancer TherapyOvarian CancerDrug ResistanceRadiation Oncology
Publications per year
2018–2019
2
2
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
Yajie Cui, Fengqin Wu, Defu Tian et al. · Oncology Reports · 2018 · 78 citations · Full text
CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling
Fengqin Wu, Jingjing Zhou · BMC Cancer · 2019 · 46 citations · Full text
Rows per page
1–2 of 2